Elimination of HSP90 activity in tumor cells inhibited their migration, invasiveness and metastatic potential, while activation of the NANOG-dependent HSP90/TCLA1/AKT signaling pathway augmented significantly the stemness of tumor cells [241,242]. Here, AKT1 is linked to neoplasm.